“…For the study published as an abstract, no data at all were provided concerning cycle management (Table 1). 21 In other cases, regarding the management of the OPU cycle, for downregulation, one study used GnRH agonists in a long protocol, 22 three studies used daily GnRH antagonists, 12,25,26 one study used either GnRH agonists in a short protocol or priming with progestins, 19 four studies used either GnRH agonists in a long protocol or daily GnRH antagonists, 9,20,23,24 and one study GnRH agonists or antagonists, reporting the data separately for these two groups 24 . Further, in one study, three different protocols were used: boost GnRH agonists, GnRH agonists in a long protocol, or GnRH antagonists, 18 while in another, six different protocols were used: ultra‐short, short, long, and modified ultra‐long GnRH agonist protocols, a GnRH antagonist protocol, or a mini‐stimulation protocol 27 …”